BioSig Technologies, Inc. announced its intention to offer shares of common stock through an underwritten public offering.
The offering is subject to market conditions with no guaranteed timing, size, or terms.
Proceeds from the offering will be used to purchase gold bullion, for working capital, and general corporate purposes.
Public Offering Announcement
BioSig Technologies, Inc. intends to offer shares of common stock through an underwritten public offering.
Use of Proceeds
The net proceeds from the offering will be used to purchase gold bullion, for working capital, and general corporate purposes.
Book-Running Managers
Clear Street and Needham & Company are acting as joint book-running managers of the offering.
Registration Statement
The offering is made pursuant to a shelf registration statement on Form S-3 (File No. 333-276298) declared effective by the SEC.
Forward-Looking Statements
The press release contains forward-looking statements related to future business and financial performance.
- BioSig Technologies aims to enhance its financial position through the public offering and use of proceeds for strategic investments.
- The collaboration with Clear Street and Needham & Company indicates strong support and interest from leading entities in the industry.
The proposed public offering by BioSig Technologies Inc. signifies a strategic move to strengthen its financial position and advance its investment strategies. The collaboration with experienced book-running managers adds credibility to the offering process.